MUSC researchers used machine learning on fMRI scans to predict which smokers would benefit from repetitive transcranial magnetic stimulation (rTMS) for quitting smoking.
Key Details
- 1MUSC study combines machine learning and fMRI to personalize rTMS for smoking cessation.
- 242 participants took part in an earlier study, split into real vs sham TMS groups.
- 3The salience network's connectivity in the brain, analyzed by AI, correlated best with positive rTMS outcomes.
- 4Machine learning enabled predictions of individual responsiveness to rTMS based on brain network analysis.
- 5Study published in Brain Connectivity; NIH grant support cited.
- 6The research establishes groundwork for precision neuromodulation and larger future trials.
Why It Matters
This study demonstrates how imaging AI can enhance precision medicine by analyzing fMRI scans to tailor neuromodulation therapies. The approach could extend to other substance use disorders, highlighting a broader potential impact for radiology-based AI tools.
Source
EurekAlert
Related News
•EurekAlert
AI Accelerates Radiopharmaceuticals, Boosts Personalized Dosimetry in Cancer
Machine learning is driving advancements in radiopharmaceutical drug discovery and optimizing patient-specific dosimetry for precision cancer therapy.
•EurekAlert
Physicians Overly Trust Erroneous AI, Ignore Contradictory Evidence
Physicians tend to trust incorrect AI advice, even when evidence contradicts it, suggesting risks in clinical decision-making with AI tools.
•EurekAlert
Concerns Raised Over Unverified Datasets in AI Health Prediction Models
A new study finds widely used AI health prediction models are built on datasets with unverifiable origins, raising safety and validity concerns.